The €231m Lyxor MSCI EMU Small Cap DR UCITS ETF (MMS) and the €402m Lyxor EURO STOXX Banks UCITS ETF (BNKE) are already listed on exchanges across Europe but as of 23 July, UK investors will be able to access the two products as well.
MMS and BNKE are two of Lyxor’s larger European ETF exposures. Both have delivered positive returns this year with MMS jumping 17.5% and BNKE returning 7.6%.
Although investors have been holding back from buying into Europe this year, Adam Laird (pictured), head of ETF strategy, northern Europe, at Lyxor, is predicting a reversal.
“Regarding the cross-listings, we have had growing client interest in these two funds, particularly from UK investors.
“Therefore, we have cross-listed the products on the LSE to make them more accessible when the tide turns,” Laird explained.
MMS is also listed on Euronext, the SIX Swiss Exchange, the Borsa Italiana and Xetra (LGWU) while BNKE is listed on Euronext, BX Swiss, the Borsa Italiana and Xetra (LYBK).
Earlier this month, Lyxor launched Europe's first emerging market ETF which excludes Chinese companies, the Lyxor MSCI Emerging Markets ex China UCITS ETF (EMXC).